Geron Corp. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Geron Corp.

GERN 1.150

-0.4%

12:27 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: LJM	2/12/2007 2:27:58 PM
	of 3576

Geron Gets FDA Clearance For Cancer Vaccine Trials >GERN Feb 12, 2007 14:02:55 (ET) Geron Corp. (GERN) said Monday that it has received clearance from the U.S. Food and Drug Administration to proceed with the clinical development of the company's telomerase cancer vaccine GRNVAC1. The Menlo Park, Calif., biopharmaceutical company filed an investigational new-drug application with the FDA last November for the drug and now plans to proceed with Phase I clinical trials of GRNVAC1 for patients with acute myelogenous leukemia, according to a Securities and Exchange Commission filing. -Antonie Boessenkool, Dow Jones Newswires; 202-862-7139; antonie.boessenkool@dowjones.com (END) Dow Jones Newswires February 12, 2007 14:02 ET (19:02 GMT)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next